Moxifloxacin

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on May 30, 2019.

Return to the list of Patented Medicine Litigation page.





Moxifloxacin

AVELOX I.V., VIGAMOX, IZILOX, IZILOX I.V., AVELOX – Bayer Inc. (NOC Search)

Patents:

  • 1340114: , NOVOPHARM, PHARMACEUTICAL PARTNERS, MYLAN, PHARMASCIENCE, TEVA, APOTEX, ACTAVIS, COBALT, AURO
  • 1340553: TEVA
  • 2086914: TEVA, PHARMASCIENCE, MYLAN, AURO, COBALT, NOVOPHARM, APOTEX
  • 2107812: MYLAN, PHARMASCIENCE
  • 2192418: APOTEX, ACTAVIS, AURO, COBALT, PHARMASCIENCE, MYLAN, TEVA, NOVOPHARM, PHARMACEUTICAL PARTNERS,
  • 2342211: TEVA, COBALT, ACTAVIS, APOTEX
  • 2378424: , PHARMACEUTICAL PARTNERS

Unknown/Other

ACTAVIS

APOTEX

AURO

COBALT

MYLAN

NOVOPHARM

PHARMACEUTICAL PARTNERS

PHARMASCIENCE

TEVA


Return to the Patented Medicine Litigation page.

Canadian Intellectual Property